When Linda O’Boyle was diagnosed with bowel cancer, her doctors told her she could boost her chances of survival by adding the drug cetuximab to her regimen. But the rationing body for Britain’s National Health Service, the National Institute of Health and Clinical Excellence NICE, had previously ruled that the drug was not cost-effective and therefore would not be paid for by the government. So O’Boyle liquidated her savings and paid for the drug herself. But this is not allowed under NHS rules. When government bureaucrats found out that O’Boyle had purchased the drug with her own money, she was denied NHS treatment and died within months.
Related articles by Zemanta
- Why the NHS shouldn’t be spared from cuts (newstatesman.com)
- British Conservatives now looking at NHS for budget cuts (americablog.com)
- Video: Obama’s Cms Nominee Says Health Systems “Must Redistribute Wealth” (healthcarebs.com)